• Prelude Therapeutics Hits New 52-Week High of $5.67, Up 527.79% MarketsMojo Sun, 05 Jul 2026 11:31:55 GMT
• Citizens reiterates Prelude Therapeutics stock rating on IND filing Investing.com Wed, 01 Jul 2026 07:00:00 GMT
• Prelude Therapeutics (PRLD) Surges 7.4%: Breakout or Bounce? - FRAMA Signal dars.gov.et Tue, 30 Jun 2026 07:00:00 GMT
• Prelude Therapeutics Incorporated(NasdaqGS:PRLD) added to Russell 2500 Growth Benchmark marketscreener.com Mon, 29 Jun 2026 19:44:00 GMT
• Prelude Therapeutics Incorporated(NasdaqGS: PRLD) added to Russell Microcap Index marketscreener.com Mon, 29 Jun 2026 05:41:52 GMT
• Prelude Therapeutics Incorporated(NasdaqGS: PRLD) added to Russell 2500 Index marketscreener.com Sun, 28 Jun 2026 07:00:00 GMT
• Prelude Therapeutics Incorporated(NasdaqGS:PRLD) added to Russell 2000 Dynamic Index marketscreener.com Sun, 28 Jun 2026 07:00:00 GMT
• Prelude Therapeutics (PRLD) Q1 2026 Earnings: Narrowed Loss Beats Estimates, Pipeline Execution in Focus dars.gov.et Sat, 27 Jun 2026 07:00:00 GMT
• prelude therapeutics inc (prld) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 24 Jun 2026 07:00:00 GMT
• Prelude Therapeutics (PRLD) Edges Higher, Approaches Key Resistance at $4.60 - Technical Analysis dars.gov.et Tue, 23 Jun 2026 07:00:00 GMT
• prelude therapeutics (prld) slips slightly as traders eye key support zone - wide range bar Město Břeclav Sun, 21 Jun 2026 21:35:20 GMT
• prelude therapeutics (prld) edges lower as stock tests key support level - add alert dars.gov.et Sun, 21 Jun 2026 07:00:00 GMT
• prelude therapeutics inc (prld) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 05:34:01 GMT
• prelude therapeutics inc (prld) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 21:59:18 GMT
• prelude therapeutics inc (prld) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 21:57:33 GMT
• Prelude Therapeutics Inc (PRLD) Valuation: PE, PB & Fair Value Analysis TradingKey Wed, 17 Jun 2026 21:53:21 GMT
• prelude therapeutics inc (prld) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 21:47:07 GMT
• prelude therapeutics inc (prld) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 21:33:11 GMT
• prelude therapeutics inc (prld) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 21:29:55 GMT
• prelude therapeutics inc (prld) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 21:20:53 GMT
• PRLD Q1 2026 Earnings: Smaller-than-expected loss as clinical pipeline advances - Management Tone Analysis dars.gov.et Tue, 16 Jun 2026 07:00:00 GMT
• prelude therapeutics inc (prld) earnings forecast: future eps & revenue growth estimates TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• prelude therapeutics inc (prld) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• prelude therapeutics inc (prld) valuation: pe, pb & fair value analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• prelude therapeutics inc (prld) risk assessment: volatility, financial risk & investment risk TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• prld q1 2026 earnings: eps beat drives strong stock reaction - pretax income report newsline.com Sun, 14 Jun 2026 01:46:15 GMT
• market sentiment around loss-making prelude therapeutics incorporated (nasdaq:prld) Moomoo Sat, 13 Jun 2026 07:00:00 GMT
• prelude therapeutics (prld) surges 9.25%: biotech stock tests key resistance - symmetrical triangle newsline.com Fri, 12 Jun 2026 20:40:20 GMT
• prelude therapeutics shareholders back leadership and governance TipRanks Wed, 10 Jun 2026 21:01:27 GMT
• [form 4] prelude therapeutics inc insider trading activity Stock Titan Wed, 10 Jun 2026 20:22:39 GMT
• prelude therapeutics (prld) director receives 38,000 stock options at $3.94 strike Stock Titan Wed, 10 Jun 2026 20:12:25 GMT
• Prelude Therapeutics (PRLD) director granted 38,000 stock options at $3.94 Stock Titan Wed, 10 Jun 2026 07:00:00 GMT
• director at prelude therapeutics (prld) awarded 38,000 stock options Stock Titan Wed, 10 Jun 2026 07:00:00 GMT
• director at prelude therapeutics (prld) receives 38,000 stock options at $3.94 strike Stock Titan Wed, 10 Jun 2026 07:00:00 GMT
• prelude therapeutics (prld) shareholders back directors, auditor and say-on-pay Stock Titan Wed, 10 Jun 2026 07:00:00 GMT
• prld: all proposals passed, directors elected, auditor ratified, and no shareholder questions submitted TradingView Tue, 09 Jun 2026 13:02:26 GMT
• prld: all director, auditor, and executive compensation proposals were approved by shareholder vote TradingView Tue, 09 Jun 2026 07:00:00 GMT
• prelude therapeutics stock (us74065l1089): clinical pipeline progress keeps biotech on the radar AD HOC NEWS Mon, 08 Jun 2026 13:49:58 GMT
• prld technical analysis | trend, signals & chart patterns | prelude therapeutics inc (nasdaq:prld) ChartMill Fri, 05 Jun 2026 07:00:00 GMT
• prelude therapeutics rises pre-market with focus on two cancer drugs Bez Kabli Thu, 04 Jun 2026 08:45:34 GMT
• prelude therapeutics stock (us74065l1089): shares trade steady as pipeline and cash runway remain in AD HOC NEWS Thu, 04 Jun 2026 07:00:00 GMT
• prelude therapeutics stock (us74065l1089): shares trade quietly after recent quarterly update Ad-hoc-news.de Tue, 02 Jun 2026 07:00:00 GMT
• goldman sachs initiates coverage on prelude therapeutics: what it could mean for investors - eps growth report newsline.com Mon, 01 Jun 2026 07:00:00 GMT
• prld technical analysis | trend, signals & chart patterns | prelude therapeutics inc (nasdaq:prld) ChartMill Mon, 01 Jun 2026 07:00:00 GMT
• Goldman Sachs Initiates Coverage of Prelude Therapeutics (PRLD) Yahoo Finance Sun, 31 May 2026 07:00:00 GMT
• wall street analysts think prelude therapeutics (prld) could surge 33.59%: read this before placing a bet MSN Fri, 29 May 2026 08:26:09 GMT
• prld q1 2026 earnings: narrower-than-expected loss surprises positively - downward estimate revision dars.gov.et Fri, 29 May 2026 07:00:00 GMT
• prld stock price, quote & chart | prelude therapeutics inc (nasdaq:prld) ChartMill Fri, 29 May 2026 07:00:00 GMT
• PRLD Q1 2026 Earnings: Narrower-Than-Expected Loss as Clinical Pipeline Advances - EPS Surprise History dars.gov.et Wed, 27 May 2026 07:00:00 GMT
• prelude therapeutics (prld) extends gains: support holds, resistance in focus - money flow newsline.com Wed, 27 May 2026 07:00:00 GMT
• prelude therapeutics announces first quarter 2026 financial results and provides corporate update geneonline.com Tue, 26 May 2026 21:18:17 GMT
• Prelude Therapeutics Q1 2026 Earnings: Narrowing Losses as Pipeline Advances - Profit Warning Alert dars.gov.et Sat, 23 May 2026 07:00:00 GMT
• prld q1 2026 earnings: narrower loss than anticipated as clinical pipeline advances - segment revenue breakdown newsline.com Sat, 23 May 2026 07:00:00 GMT
• prelude therapeutics (prld) price target increased by 11.49% to 7.01 MSN Mon, 18 May 2026 14:32:11 GMT
• prelude therapeutics incorporated (nasdaq:prld) reported earnings last week and analysts are already upgrading their estimates Sahm Sun, 17 May 2026 07:21:14 GMT
• prelude therapeutics (prld) price target increased by 11.49% to 7.01 MSN Sun, 17 May 2026 00:18:09 GMT
• Earnings Beat: Prelude Therapeutics Incorporated (NASDAQ:PRLD) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their F... Yahoo Finance Sat, 16 May 2026 07:00:00 GMT
• Prelude Therapeutics Incorporated (NASDAQ:PRLD) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates simplywall.st Sat, 16 May 2026 07:00:00 GMT
• prelude therapeutics initiated with early-stage biotech at goldman sachs TipRanks Fri, 15 May 2026 09:59:31 GMT
• prelude therapeutics (prld) price target increased by 11.49% to 7.01 MSN Fri, 15 May 2026 08:36:39 GMT
• Goldman Sachs initiates Prelude Therapeutics stock coverage as Early-Stage Biotech Investing.com Fri, 15 May 2026 07:00:00 GMT
• prelude therapeutics (prld) price target increased by 11.49% to 7.01 MSN Thu, 14 May 2026 19:33:04 GMT
• prelude therapeutics (prld) losses narrow in q1 2026 challenging bearish narratives Sahm Wed, 13 May 2026 07:00:00 GMT
• jefferies raises prelude therapeutics stock price target on pipeline progress by investing.com Investing.com Australia Wed, 13 May 2026 07:00:00 GMT
• prelude (prld) reports progress on strategic initiatives and cas GuruFocus Tue, 12 May 2026 13:47:05 GMT
• prelude therapeutics (nasdaq:prld) reports narrower quarterly loss, shares rise on cash runway extension ChartMill Tue, 12 May 2026 12:32:07 GMT
• prelude therapeutics launches phase 1 trial and extends runway TipRanks Tue, 12 May 2026 12:07:47 GMT
• Prelude Therapeutics Inc 1Q 2026: Revenue $4.58M, EPS $(0.13) — 10-Q Summary TradingView Tue, 12 May 2026 07:00:00 GMT
• prelude therapeutics reports first quarter 2026 financial results and provides corporate update GlobeNewswire Tue, 12 May 2026 07:00:00 GMT
• jefferies raises prelude therapeutics stock price target on pipeline progress Investing.com Tue, 12 May 2026 07:00:00 GMT
• prelude therapeutics q1 net loss narrows as expenses fall TradingView Tue, 12 May 2026 07:00:00 GMT
• prelude therapeutics initiates phase 1 study of prt12396 and provides r&d pipeline update Quiver Quantitative Tue, 12 May 2026 07:00:00 GMT
• prelude therapeutics (nasdaq: prld) trims q1 2026 loss and extends cash runway to 2028 Stock Titan Tue, 12 May 2026 07:00:00 GMT
• prelude therapeutics reports q1 2026 results, advances precision oncology pipeline and extends cash runway to 2028 Minichart Tue, 12 May 2026 07:00:00 GMT
• prelude therapeutics is maintained at buy by hc wainwright & co. Moomoo Mon, 11 May 2026 08:49:40 GMT
• prelude therapeutics (prld) price target increased by 19.35% to 6.29 MSN Fri, 08 May 2026 18:58:17 GMT
• d. boral capital initiates prelude therapeutics(prld.us) with buy rating, announces target price $9 富途牛牛 Fri, 08 May 2026 07:38:33 GMT
• wall street analysts think prelude therapeutics (prld) could surge 33.59%: read this before placing a bet Yahoo Finance Fri, 08 May 2026 07:00:00 GMT
• prelude therapeutics inc expected to post a loss of 24 cents a share - earnings preview TradingView Fri, 08 May 2026 07:00:00 GMT
• prld technical analysis | trend, signals & chart patterns | prelude therapeutics inc (nasdaq:prld) ChartMill Fri, 08 May 2026 07:00:00 GMT
• prelude therapeutics (prld) price target increased by 19.35% to 6.29 MSN Thu, 07 May 2026 14:20:03 GMT
• prelude therapeutics (prld) price target increased by 19.35% to 6.29 MSN Wed, 06 May 2026 18:21:39 GMT
• prld initiates coverage on prelude therapeutics -- price target announced at $9.00 GuruFocus Tue, 05 May 2026 05:41:39 GMT
• prelude therapeutics (prld) price target increased by 19.35% to 6.29 MSN Tue, 05 May 2026 05:30:55 GMT
• d. boral capital initiates prelude therapeutics(prld.us) with buy rating, announces target price $9 Moomoo Tue, 05 May 2026 03:57:20 GMT
• d. boral capital initiates prelude therapeutics(prld.us) with buy rating, announces target price $9 Moomoo Mon, 04 May 2026 12:35:01 GMT
• PRLD Initiates Coverage On Prelude Therapeutics -- Price Target Announced at $9.00 GuruFocus Mon, 04 May 2026 07:00:00 GMT
• boral capital initiates prelude stock with buy on oncology pipeline by investing.com Investing.com UK Mon, 04 May 2026 07:00:00 GMT
• d boral capital initiates coverage of prelude therapeutics (prld) with buy recommendation MSN Mon, 04 May 2026 07:00:00 GMT
• prelude therapeutics initiated with a buy at d. boral capital TipRanks Mon, 04 May 2026 07:00:00 GMT
• prelude therapeutics (prld) price target increased by 19.35% to 6.29 MSN Sun, 03 May 2026 16:06:33 GMT
• delaware's 2026 most influential & inspiring in industry & development Delawareonline.com Sun, 03 May 2026 07:00:00 GMT
• prelude therapeutics (prld) price target increased by 19.35% to 6.29 MSN Fri, 01 May 2026 08:03:59 GMT
• Prelude Therapeutics (PRLD) Presents Preclinical Data for KAT6A Degarader PRT13722 in Breast Cancer Yahoo Finance Fri, 01 May 2026 07:00:00 GMT
• prelude therapeutics inc expected to post a loss of 24 cents a share - earnings preview TradingView Fri, 01 May 2026 07:00:00 GMT
• prelude therapeutics (nasdaq:prld) rating increased to hold at zacks research MarketBeat Thu, 30 Apr 2026 11:51:12 GMT
• 12 health care stocks moving in thursday's after-market session Benzinga Thu, 30 Apr 2026 07:00:00 GMT
• prelude therapeutics (nasdaq: prld) outlines 2026 proxy votes on directors, pay and auditor Stock Titan Wed, 29 Apr 2026 20:08:12 GMT
• prelude therapeutics (prld) price target increased by 19.35% to 6.29 MSN Wed, 29 Apr 2026 13:00:11 GMT
• short interest in prelude therapeutics incorporated (nasdaq:prld) decreases by 22.1% MarketBeat Wed, 29 Apr 2026 07:00:00 GMT
• ra capital reports 7.88m-share prelude therapeutics (prld) stake Stock Titan Tue, 28 Apr 2026 21:13:28 GMT
• prelude therapeutics (prld) expected to announce quarterly earnings on tuesday MarketBeat Tue, 28 Apr 2026 14:55:58 GMT
• h.c. wainwright maintains prelude therapeutics(prld.us) with buy rating, raises target price to $8 富途牛牛 Tue, 28 Apr 2026 08:49:55 GMT
• H.C. Wainwright raises Prelude Therapeutics price target to $8 Investing.com Tue, 28 Apr 2026 07:00:00 GMT
• prelude therapeutics price target raised to $8 from $5 at h.c. wainwright TipRanks Tue, 28 Apr 2026 01:01:05 GMT
• prld maintained by hc wainwright & co. -- price target raised to $8 GuruFocus Mon, 27 Apr 2026 13:21:41 GMT
• hc wainwright issues positive forecast for prelude therapeutics (nasdaq:prld) stock price MarketBeat Mon, 27 Apr 2026 12:56:40 GMT
• h.c. wainwright maintains prelude therapeutics(prld.us) with buy rating, raises target price to $8 富途牛牛 Mon, 27 Apr 2026 12:33:00 GMT
• prelude therapeutics is maintained at buy by hc wainwright & co. Moomoo Mon, 27 Apr 2026 07:00:00 GMT
• prelude therapeutics price target raised to $8 from $5 at h.c. wainwright TipRanks Mon, 27 Apr 2026 07:00:00 GMT
• prelude therapeutics appoints charles morris as chief medical officer MyChesCo Sun, 26 Apr 2026 18:26:31 GMT
• prelude therapeutics (prld) price target increased by 23.81% to 4.42 MSN Sun, 26 Apr 2026 12:47:48 GMT
• prelude therapeutics (prld) price target increased by 23.81% to 4.42 MSN Sat, 25 Apr 2026 14:59:10 GMT
• Thursday’s insider trading: Major buys at Prelude, sells at NuScale Investing.com Fri, 24 Apr 2026 07:00:00 GMT
• orbimed entities acquire $12.5m in prelude therapeutics stock by investing.com Investing.com South Africa Fri, 24 Apr 2026 07:00:00 GMT
• prelude therapeutics director david p. bonita acquires $12.5 million in stock by investing.com Investing.com South Africa Fri, 24 Apr 2026 07:00:00 GMT
• massive insider buying spree signals bold confidence in prelude therapeutics TipRanks Fri, 24 Apr 2026 02:47:43 GMT
• prelude therapeutics (nasdaq:prld) director david bonita buys 2,815,315 shares MarketBeat Thu, 23 Apr 2026 23:49:21 GMT
• orbimed funds boost prelude therapeutics (nasdaq: prld) stake with 2.82m-share buy Stock Titan Thu, 23 Apr 2026 22:48:25 GMT
• Prelude Therapeutics director David P. Bonita acquires $12.5 million in stock Investing.com Thu, 23 Apr 2026 07:00:00 GMT
• Orbimed entities acquire $12.5m in Prelude Therapeutics stock By Investing.com Investing.com Nigeria Thu, 23 Apr 2026 07:00:00 GMT
• orbimed funds add prelude therapeutics (prld) shares at $4.44 in offering Stock Titan Thu, 23 Apr 2026 07:00:00 GMT
• prelude therapeutics (nasdaq:prld) director buys $12,499,998.60 in stock MarketBeat Thu, 23 Apr 2026 07:00:00 GMT
• massive insider buying spree signals bold confidence in prelude therapeutics TipRanks Thu, 23 Apr 2026 07:00:00 GMT
• Prelude Therapeutics closes $90M stock sale as life sciences investments pick up steam The Business Journals Wed, 22 Apr 2026 07:00:00 GMT
• prelude therapeutics appoints charles morris as chief medical officer MyChesCo Wed, 22 Apr 2026 07:00:00 GMT
• prelude therapeutics (prld) price target increased by 23.81% to 4.42 MSN Tue, 21 Apr 2026 19:01:51 GMT
• Prelude Therapeutics Prices $90M Underwritten Offering The Clinical Trial Vanguard Tue, 21 Apr 2026 07:00:00 GMT
• prelude therapeutics enters underwriting for $85.5 million equity offering led by ra capital TradingView Tue, 21 Apr 2026 07:00:00 GMT
• prelude therapeutics prices public offering to extend runway TipRanks Tue, 21 Apr 2026 07:00:00 GMT
• prelude therapeutics presents preclinical data on breast cancer drug by investing.com Investing.com India Tue, 21 Apr 2026 06:29:41 GMT
• prelude therapeutics (prld) unveils promising preclinical data f GuruFocus Mon, 20 Apr 2026 16:52:30 GMT
Prelude Therapeutics Incorporated(NASDAQ:PRLD) 
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of small molecule therapies optimized to target the key driver mechanisms in cancers. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid...
Website: http://www.preludetx.com
Founded: 2016
Full Time Employees: 55
CEO: Krishna Vaddi
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends